HealthNews

Cannabis Shields You From COVID-19 And There’s Science To Prove It Because Of This New Study

So you’re double-dosed on vaccinations with a booster on top? That’s cool and all, but there’s newer way to boost your immunity. This new study says coronavirus infections can by stopped by cannabis. Some molecular compounds in cannabis can stop the COVID-19-causing virus from entering your cells.

The scientific study’s authors write: “with widespread use of cannabinoids, resistant variants could still arise, but the combination of vaccination and CBDA/CBGA treatment should create a more challenging environment with which SARS-CoV-2 must contend, reducing the likelihood.”



Apparently, this means stoners have played a crucial role in helping fight this global pandemic. Jokes aside, the researchers who discovered this are from Oregon Health & Sciences University and Oregon State University. The new findings are published in the Journal of Natural Products, which is peer-reviewed by other scientists.

The researchers ran tests on cannabigerolic acid and cannabidiolic acid. These compounds are better known as CBD, which isn’t responsible for the typical high after consuming weed. That quality belongs to THC — a type of which is tetrahydrocannabinolic acid. The researchers wanted to test that, but it’s a controlled substance, so they couldn’t. On the other hand, you can get CBD-infused food and other products without showing ID.

They tested the CBD on cells and then introduced SARS-COV-2 RNA variants. They discovered that the CBD was “virus neutralizing” on the alpha and beta variants, which is “a trend that will hopefully extend to other existing and future variants” although they’re yet to test delta and omicron.

That sounds great, but don’t expect to load up on cannabis the fun way. The scientists recommend you take CBD orally (pill or liquid) because of the high concentration required to effectively block out COVID-19 viruses. Luckily, CBD has a long history of safe use in humans according to Richard Van Breemen, Professor of Medicinal Chemistry and one of the study’s authors.



Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
Back to top button